Skip to main content
Premium Trial:

Request an Annual Quote

Tepnel Adds Illumina's iScan System to Services Offering

NEW YORK (GenomeWeb News) – Tepnel Life Sciences has added Illumina’s iScan System to the collection of instruments it uses to perform genetic analysis services for customers.
 
Manchester, UK-based Tepnel said that the addition of the iScan makes the firm the first commercial provider of iScan services within the UK. It said that it now offers a full suite of complementary services from DNA extraction through to bioinformatics.
 
According to Tepnel, the iScan is capable of generating up to 225 million genotypes per day. That is in addition to the other platforms and techniques for SNP-based investigations that Tepnel uses for human and non-human research and clinical applications.
 
"This new addition to our service opens up the possibility to our customers of whole genome association, focused content analysis, copy number variation analysis and, epigenetics on both human and non-human samples, all within a regulatory compliant environment,” said David Scott, general manager of Tepnel’s Livingston facility, in a statement.
 
Illumina launched the iScan system, which can complete genotyping studies up to six times faster than studies run on its BeadStation, earlier this year.
 

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.